Rua Bioscience Limited logo

Record Sales in March for New Zealand

Operational Update30 March 2025RUAHealthcare

PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com





FOR PUBLIC RELEASE



31 March 2025



Record Sales in March for New Zealand



Rua Bioscience (NZX: RUA) is pleased to provide the following business update, highlighting

positive sales performance across New Zealand, Australia, and Germany.


New Zealand – Record month


March marked a significant milestone in Rua’s home market, with the company achieving its

highest-ever monthly sales in New Zealand. This performance is more than a company

milestone – it’s a strong signal that Rua is not only increasing its market share, but that the

overall medicinal cannabis market is expanding.


Australia: Record Flower Sales Reflect Deepening Market Presence


Australia also delivered a record month, with Rua achieving its highest-ever unit sales of key

medicinal cannabis flower product lines. This strong result reflects the company’s consistent

presence in the Australian market, backed by growing relationships with prescribers,

distributors, and patients. Rua continues to view Australia as a strategically important growth

opportunity and is investing in strengthening its commercial footprint.


Germany: High Demand


In Germany, demand for Rua’s products remains strong. Current sales are temporarily

limited by a supply shortage to meet our increased demand, Rua expects growth to resume

as the supply chain capacity is restored over the next quarter. The German market remains a

core focus for the company’s international expansion strategy.


Rua's continued focus on quality, accessible products is resonating with patients and

prescribers alike. With new product launches planned in the coming months, Rua is well

positioned to maintain and accelerate this growth trajectory. The company is proud to be a

key player in shaping the future of medicinal cannabis in Aotearoa New Zealand.


Rua Bioscience looks forward to keeping shareholders updated as we continue this positive

growth trajectory and unlock new opportunities.


ENDS  

MARKET UPDATE


PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com


The person who authorised this announcement:


Paul Naske

Chief Executive Officer

paul.naske@ruabio.com

+64 21 445154

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.